Senseonics (SENS) announced it has filed for CE Mark registration for the Eversense 365 CGM system.Maximize Your Portfolio with Data Driven ...

Senseonics (NYSE:SENS) announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Transforming global health demands smart chemistry, addressing urgent health challenges through innovative, durable medical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Senseonics Holdings, Inc. (NYSE:SENS – Get Free Report) shot up 8.4% on Friday . The company traded as high as $1.12 and last traded at $1.10. 4,920,939 shares were traded during mid-day ...

Senseonics Holdings (NYSEAMERICAN:SENS) makes implantable continuous glucose monitoring (CGM) systems that help people with diabetes track their blood sugar in real time. It offers the Eversense line ...

Senseonics Holdings (NYSEAMERICAN:SENS) makes implantable continuous glucose monitoring (CGM) systems that help people with diabetes track their blood sugar in real time. It offers the Eversense ...